We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

108 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 6

65% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 20

7% more funds holding

Funds holding: 101 → 108 (+7)

1.2% less ownership

Funds ownership: 26.85% → 25.65% (-1.2%)

7% less capital invested

Capital invested by funds: $131M → $123M (-$8.66M)

17% less call options, than puts

Call options by funds: $1.16M | Put options by funds: $1.39M

Holders
108
Holders Change
+7
Holders Change %
+6.93%
% of All Funds
1.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
33
Reduced
20
Closed
6
Calls
$1.16M
Puts
$1.39M
Net Calls
-$234K
Net Calls Change
-$721K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$3.2M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.65M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.04M
4
KAS
Kestra Advisory Services
Texas
+$886K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$576K

Top Sellers

Rank Fund Capital Flow
1
PAG
Pinnacle Advisory Group
Maryland
-$20.2M
2
HighTower Advisors
HighTower Advisors
Illinois
-$2.21M
3
FTUS
Flow Traders U.S.
New York
-$946K
4
LPL Financial
LPL Financial
California
-$407K
5
UBS Group
UBS Group
Switzerland
-$231K
Name Holding Trade Value Shares
Change 		Change in
Stake
MWA
51
MFA Wealth Advisors
Pennsylvania
$305K – – –
Creative Planning
52
Creative Planning
Kansas
$303K +$22.6K +137 +8%
B
53
Bailard
California
$300K – – –
CIBC World Market
54
CIBC World Market
Ontario, Canada
$296K -$21.3K -129 -7%
TRCT
55
Tower Research Capital (TRC)
New York
$288K -$45.3K -275 -14%
PWP
56
Principle Wealth Partners
Connecticut
$282K +$273K +1,659 New
EDRH
57
Edmond de Rothschild Holding
Switzerland
$281K – – –
IWC
58
Integrated Wealth Concepts
Massachusetts
$273K +$494 +3 +0.2%
TCM
59
Tufton Capital Management
Maryland
$263K – – –
IAA
60
Ironsides Asset Advisors
North Carolina
$258K -$15.7K -95 -6%
WS
61
Wedbush Securities
California
$254K -$70K -425 -22%
HFAS
62
Hummer Financial Advisory Services
Illinois
$239K – – –
CB
63
Commerce Bank
Missouri
$221K – – –
GW
64
GW & Wade
Massachusetts
$220K – – –
FANJ
65
Financial Architects (New Jersey)
New Jersey
$216K – – –
FHC
66
First Heartland Consultants
Missouri
$215K – – –
D
67
Diversified
Delaware
$197K +$200K +1,215 New
Simplex Trading
68
Simplex Trading
Illinois
$139K +$136K +824 New
Citigroup
69
Citigroup
New York
$117K +$659 +4 +0.6%
AF
70
Advisornet Financial
Minnesota
$115K – – –
William Blair & Company
71
William Blair & Company
Illinois
$115K +$37.1K +225 +50%
KTC
72
Kistler-Tiffany Companies
Pennsylvania
$92K +$329 +2 +0.4%
WWMSC
73
Wagner Wealth Management (South Carolina)
South Carolina
$80K +$77.4K +470 New
Bank of Montreal
74
Bank of Montreal
Ontario, Canada
$78K +$72.5K +440 New
Northwestern Mutual Wealth Management
75
Northwestern Mutual Wealth Management
Wisconsin
$77K -$40.4K -245 -35%
1 2
3
4 5

BBH Hedge Fund Activity: Q4 2020 in Review

108 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2020, worth a combined $123M — down 6.6% from $131M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BBH positions and 6 closed out — a net gain of 11 holders — while 33 added to existing stakes and 20 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $3.2M. The largest seller was Pinnacle Advisory Group, exiting entirely with an estimated $20.2M sold.

  • 108 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2020, up from 101 in Q3 2020.
  • Funds reported $123M of VanEck Biotech ETF stock for Q4 2020, down 6.6% quarter-over-quarter.
  • 17 funds opened new VanEck Biotech ETF positions in Q4 2020 and 6 closed out, a net change of +11 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2020 was Goldman Sachs, an estimated $3.2M added.
  • The largest VanEck Biotech ETF seller in Q4 2020 was Pinnacle Advisory Group, an estimated $20.2M sold.

Based on aggregated 13F filings for Q4 2020.